Form 4: Shattuck Labs Director Receives Stock Option Grant
Director Equity Grant
Director George Golumbeski was granted 81,000 stock options in Shattuck Labs, Inc. as part of standard equity compensation.
Summary
- Director George Golumbeski received a grant of 81,000 stock options on May 29, 2026.
- The options have an exercise price of $5.95 per share.
- The options are set to expire on May 29, 2036.
- Vesting occurs on the earlier of the one-year anniversary of the grant or the date of the next annual meeting of stockholders.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation that carries no significant signal regarding company performance.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
Negatives
- Potential for future dilution of existing shareholders upon the exercise of these options.
Risks
- Market volatility affecting the value of the underlying common stock relative to the $5.95 exercise price.
Future Outlook
The options vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the next annual meeting of stockholders, contingent upon continued service.
Industry Context
StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice in the biotechnology sector to ensure board members remain incentivized to oversee long-term strategic growth.
Comparison to Industry Standards
- The grant size and vesting schedule are consistent with typical director compensation packages for small-cap biotechnology firms.
- The use of time-based vesting is a standard industry practice for board-level equity incentives.
Stakeholder Impact
- Minor potential dilution for existing shareholders if options are exercised.
Next Steps
- Vesting of options on the earlier of May 29, 2027, or the next annual meeting of stockholders.
Key Dates
| Date | Description |
|---|---|
| 05/29/2026 | Date of the stock option grant transaction. |
| 05/29/2036 | Expiration date of the granted stock options. |
| 06/02/2026 | Date the Form 4 was signed and filed. |
Keywords
Shattuck Labs, STTK, Form 4, Director Compensation, Stock Options, Insider Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.